Depression and BMI influences the serum vascular endothelial growth factor level

International Journal of Neuropsychopharmacology

Volumn 17, Issue 9, 2014, Pages 1409-1417

  Elfving, Betina ^a   Buttenschon, Henriette N ^a,b   Foldager, Leslie ^a,b   Poulsen, Pia H P ^a   Grynderup, Matias B ^c   Hansen, Åse M ^d,e   Kolstad, Henrik A ^c   Kaerlev, Linda ^f,g   Mikkelsen, Sigurd ^h   Borglum, Anders D ^a,b,c   Wegener, Gregers ^a   Mors, Ole ^b,c  

^a AARHUS UNIVERSITY   (Denmark)

^b Aarhus   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d National Research Centre for the Work Environment   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

^h BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Age; body mass index (BMI); depression; single nucleotide polymorphism (SNP); vascular endothelial growth factor (VEGF)

Indexed keywords

ANTIDEPRESSANT AGENT; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; GENETICS; GENOTYPE; NONPARAMETRIC TEST; RETROSPECTIVE STUDY;

ADULT; BODY MASS INDEX; DEPRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904893414     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000273     Document Type: Article

References (44)

1. Audet MC, Anisman H (2013) Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses. Front Cell Neurosci 7:68. doi: 10.3389/ fncel.2013.00068.
2. Baune BT, Adrian I, Jacobi F (2007) Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population. J Psychosom Res 62:109-118.
3. Bhattacharya A, Ziebarth JD, Cui Y (2014) PolymiTRS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res 42:D86-D91.
4. Buttenschøn HN, Kristensen AS, Buch HN, Andersen JH, Bonde JP, Grynderup M, Hansen AM, Kolstad H, Kaergaard A, Kaerlev L, Mikkelsen S, Thomsen JF, Koefoed P, Erhardt A, Woldbye DP, Borglum AD, Mors O (2011) The norepinephrine transporter gene is a candidate gene for panic disorder. J Neural Transm 118:969-976.
5. Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117:2362-2368.
6. Curtis D, Vine AE, Knight J (2008) A simple method for assessing the strength of evidence for association at the level of whole gene. Adv Appl Bioinform Chem 1:115-120.
7. Del BR, Scarlato M, Ghezzi S, Martinelli BF, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57:373-380.
8. Dome P, Teleki Z, Rihmer Z, Peter L, Dobos J, Kenessey I, Tovari J, Timar J, Paku S, Kovacs G, Dome B (2009) Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry 14:523-531.
9. Elfving B, Buttenschon HN, Foldager L, Poulsen PH, Andersen JH, Grynderup MB, Hansen AM, Kolstad HA, Kaerlev L, Mikkelsen S, Thomsen JF, Borglum AD,Wegener G, Mors O (2012) Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level. J Psychiatr Res 46:1118-1125.
10. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676.
11. Fornaro M, Rocchi G, Escelsior A, Contini P, Ghio M, Colicchio S, Berardis DD, Amore M, Fornaro P, Martino M (2013) VEGF plasma level variations in duloxetine-treated patients with major depression. J Affect Disord 151:590-595.
12. Friedman RC, Farh KK-H, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
13. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP (2011) Weak seed-pairing stability and high target-site abundance decrease the proficiency of Isy-6 and other miRNAs. Nat Struct Mol Biol 18:1139-1146.
14. Gomez-Ambrosi J, Catalan V, Rodriguez A, Ramirez B, Silva C, Gil MJ, Salvador J, Fruhbeck G (2010) Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem 21:774-780.
15. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105.
16. Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, van Meeteren LA, Samen E, Lu L, Vanwildemeersch M, Klar J, Genove G, Pietras K, Stone-Elander S, Claesson-Welsh L, Yla-Herttuala S, Lindahl P, Eriksson U (2010) Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464:917-921.
17. Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, Sano A, Ohmori T (2007) Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:658-663.
18. Isung J, Mobarrez F, Nordstrom P, Asberg M, Jokinen J (2012) Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry 13:468-473.
19. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 99:11946-11950.
20. Kaerlev L, Kolstad HA, Hansen AM, Thomsen JF, Kaergaard A, Rugulies R, Mikkelsen S, Andersen JH, Mors O, Grynderup MB, Bonde JP (2011) Are risk estimates biased in follow-up studies of psychosocial factors with low base-line participation? BMC Public Health 11:539.
21. Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L, Schweiger U (2009) Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinol 34:353-357.
22. Katsuura S, Kamezaki Y, Yamagishi N, Kuwano Y, Nishida K, Masuda K, Tanahashi T, Kawai T, Arisawa K, Rokutan K (2011) Circulating vascular endothelial growth factor is independently and negatively associated with trait anxiety and depressive mood in healthy Japanese university students. Int J Psychophysiol 81:38-43.
23. Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM, Jin R, Merikangas KR, Simon GE, Wang PS (2006) Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry 163:1561-1568.
24. Kim Y, Nam YJ, Lee C (2006) Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia. Am J Med Genet B Neuropsychiatr Genet 141B:332-335.
25. Kimura K, Hashiguchi T, Deguchi T, Horinouchi S, Uto T, Oku H, Setoyama S, Maruyama I, Osame M, Arimura K (2007) Serum VEGF - as a prognostic factor of atherosclerosis. Atherosclerosis 194:182-188.
26. Kolstad HA, Hansen AM, Kaergaard A, Thomsen JF, Kaerlev L, Mikkelsen S, Grynderup MB, Mors O, Rugulies R, Kristensen AS, Andersen JH, Bonde JP (2011) Job strain and the risk of depression: is reporting biased? Am J Epidemiol 173:94-102.
27. Kut C, Mac Gabhann F, Popel AS (2007) Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br J Cancer 97:978-985.
28. Lambrechts D et al. (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394.
29. Lee BH, Kim YK (2012) Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord 136:181-184.
30. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
31. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18:497-511.
32. Minelli A, Zanardini R, Abate M, Bortolomasi M, Gennarelli M, Bocchio-Chiavetto L (2011) Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 35:1322-1325.
33. Oranskiy SP, Yeliseyeva LN, Tsanaeva AV, Zaytseva NV (2012) Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis. Croat Med J 53:350-356.
34. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB (2006) The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 53:441-449.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
36. SiervoM, Ruggiero D, Sorice R, Nutile T, Aversano M, Iafusco M, Vetrano F, Wells JC, Stephan BC, Ciullo M (2012) Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition 28:262-266.
37. Silha JV, Krsek M, Sucharda P, Murphy LJ (2005) Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29:1308-1314.
38. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552-1562.
39. Takebayashi M, Hashimoto R, Hisaoka K, Tsuchioka M, Kunugi H (2010) Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. J Neural Transm 117:1119-1122.
40. Ventriglia M, Zanardini R, Pedrini L, Placentino A, Nielsen MG, Gennarelli M, Bocchio-Chiavetto L (2009) VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 33:146-149.
41. Viikki M, Anttila S, Kampman O, Illi A, Huuhka M, Setala-Soikkeli E, Mononen N, Lehtimaki T, Leinonen E (2010) Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci Lett 477:105-108.
42. Vincenti V, Cassano C, Rocchi M, Persico G (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493-1495.
43. World Health Organization (1993) The ICD10 classification of mental and behavioural disorders. Available at: http://www.who.int/classifications/icd/en/ bluebook.pdf (accessed 18 february 2014).
44. Wing JK, Sartorius N, Üstün TB (1998) Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN. Cambridge: Cambridge University Press/World Health Organization.